SAMe supplement may shield liver from chemo damage
NCT ID NCT06258525
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 21 times
Summary
This study tests whether taking S-adenosylmethionine (SAMe), a common supplement, can prevent liver injury caused by the chemotherapy drug oxaliplatin in people with colorectal cancer that has spread to the liver. About 30 participants will take SAMe pills daily for 3-6 months alongside their chemo, then have liver surgery. Researchers will check liver tissue for damage and compare it to past patients who did not take SAMe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cedars-Sinai Medical Center Beverly Hills
Los Angeles, California, 90211, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Cedars-Sinai Medical Center at SOCC
Los Angeles, California, 90048, United States
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.